nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—Dyclonine—Raloxifene—osteoporosis	0.404	1	CrCrCtD
Haloperidol—EBP—Raloxifene—osteoporosis	0.139	0.324	CbGbCtD
Haloperidol—SIGMAR1—Raloxifene—osteoporosis	0.0596	0.139	CbGbCtD
Haloperidol—HTR2B—Raloxifene—osteoporosis	0.0399	0.0931	CbGbCtD
Haloperidol—CYP1A1—Cholecalciferol—osteoporosis	0.0163	0.0381	CbGbCtD
Haloperidol—CYP1A2—Estropipate—osteoporosis	0.0142	0.0331	CbGbCtD
Haloperidol—CYP1A1—Estradiol—osteoporosis	0.0132	0.0307	CbGbCtD
Haloperidol—CYP2C9—Estropipate—osteoporosis	0.0128	0.0298	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0105	0.0246	CbGbCtD
Haloperidol—CYP3A7—Estradiol—osteoporosis	0.0105	0.0246	CbGbCtD
Haloperidol—ABCB1—Ethinyl Estradiol—osteoporosis	0.00798	0.0186	CbGbCtD
Haloperidol—CYP2C19—Cholecalciferol—osteoporosis	0.0079	0.0185	CbGbCtD
Haloperidol—CYP3A5—Estradiol—osteoporosis	0.0079	0.0184	CbGbCtD
Haloperidol—CYP3A4—Estropipate—osteoporosis	0.00742	0.0173	CbGbCtD
Haloperidol—CYP3A4—Calcitriol—osteoporosis	0.00742	0.0173	CbGbCtD
Haloperidol—CYP1A2—Conjugated Estrogens—osteoporosis	0.0067	0.0156	CbGbCtD
Haloperidol—CYP2C9—Cholecalciferol—osteoporosis	0.00657	0.0153	CbGbCtD
Haloperidol—CYP2C19—Estradiol—osteoporosis	0.00637	0.0149	CbGbCtD
Haloperidol—CYP2D6—Cholecalciferol—osteoporosis	0.00601	0.014	CbGbCtD
Haloperidol—CYP3A4—Ergocalciferol—osteoporosis	0.00593	0.0138	CbGbCtD
Haloperidol—CYP1A2—Estradiol—osteoporosis	0.00588	0.0137	CbGbCtD
Haloperidol—ABCB1—Conjugated Estrogens—osteoporosis	0.00586	0.0137	CbGbCtD
Haloperidol—CYP2C9—Estradiol—osteoporosis	0.0053	0.0124	CbGbCtD
Haloperidol—ABCB1—Estradiol—osteoporosis	0.00514	0.012	CbGbCtD
Haloperidol—CYP3A4—Raloxifene—osteoporosis	0.00495	0.0116	CbGbCtD
Haloperidol—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00478	0.0112	CbGbCtD
Haloperidol—CYP3A4—Cholecalciferol—osteoporosis	0.00382	0.00892	CbGbCtD
Haloperidol—CYP3A4—Conjugated Estrogens—osteoporosis	0.00351	0.00819	CbGbCtD
Haloperidol—CYP3A4—Estradiol—osteoporosis	0.00308	0.00719	CbGbCtD
Haloperidol—Loperamide—POMC—osteoporosis	0.000938	1	CrCbGaD
Haloperidol—SIGMAR1—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000935	1	CbGdCrCtD
Haloperidol—Mental disorder—Conjugated Estrogens—osteoporosis	0.000151	0.00125	CcSEcCtD
Haloperidol—Feeling abnormal—Alendronate—osteoporosis	0.00015	0.00125	CcSEcCtD
Haloperidol—Oedema—Ethinyl Estradiol—osteoporosis	0.00015	0.00124	CcSEcCtD
Haloperidol—Malnutrition—Conjugated Estrogens—osteoporosis	0.00015	0.00124	CcSEcCtD
Haloperidol—Muscle spasms—Zoledronate—osteoporosis	0.00015	0.00124	CcSEcCtD
Haloperidol—Jaundice—Estradiol—osteoporosis	0.00015	0.00124	CcSEcCtD
Haloperidol—Dry mouth—Risedronate—osteoporosis	0.000149	0.00124	CcSEcCtD
Haloperidol—Constipation—Calcitriol—osteoporosis	0.000149	0.00123	CcSEcCtD
Haloperidol—Convulsion—Pamidronate—osteoporosis	0.000148	0.00122	CcSEcCtD
Haloperidol—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000147	0.00122	CcSEcCtD
Haloperidol—Hypertension—Pamidronate—osteoporosis	0.000147	0.00122	CcSEcCtD
Haloperidol—Urticaria—Estropipate—osteoporosis	0.000147	0.00122	CcSEcCtD
Haloperidol—Vision blurred—Zoledronate—osteoporosis	0.000147	0.00122	CcSEcCtD
Haloperidol—Diarrhoea—Etidronic acid—osteoporosis	0.000146	0.00121	CcSEcCtD
Haloperidol—Body temperature increased—Estropipate—osteoporosis	0.000146	0.00121	CcSEcCtD
Haloperidol—Feeling abnormal—Ibandronate—osteoporosis	0.000146	0.00121	CcSEcCtD
Haloperidol—Tremor—Zoledronate—osteoporosis	0.000146	0.00121	CcSEcCtD
Haloperidol—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000146	0.00121	CcSEcCtD
Haloperidol—Hepatobiliary disease—Estradiol—osteoporosis	0.000145	0.0012	CcSEcCtD
Haloperidol—Urticaria—Alendronate—osteoporosis	0.000145	0.0012	CcSEcCtD
Haloperidol—Anxiety—Pamidronate—osteoporosis	0.000145	0.0012	CcSEcCtD
Haloperidol—Body temperature increased—Alendronate—osteoporosis	0.000144	0.0012	CcSEcCtD
Haloperidol—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000144	0.0012	CcSEcCtD
Haloperidol—Anaemia—Zoledronate—osteoporosis	0.000144	0.00119	CcSEcCtD
Haloperidol—Nervous system disorder—Risedronate—osteoporosis	0.000143	0.00119	CcSEcCtD
Haloperidol—Agitation—Zoledronate—osteoporosis	0.000143	0.00119	CcSEcCtD
Haloperidol—Skin disorder—Risedronate—osteoporosis	0.000142	0.00118	CcSEcCtD
Haloperidol—Body temperature increased—Raloxifene—osteoporosis	0.000142	0.00118	CcSEcCtD
Haloperidol—Vision blurred—Conjugated Estrogens—osteoporosis	0.000141	0.00117	CcSEcCtD
Haloperidol—Urticaria—Ibandronate—osteoporosis	0.000141	0.00117	CcSEcCtD
Haloperidol—Body temperature increased—Ibandronate—osteoporosis	0.00014	0.00116	CcSEcCtD
Haloperidol—Confusional state—Pamidronate—osteoporosis	0.00014	0.00116	CcSEcCtD
Haloperidol—Vertigo—Zoledronate—osteoporosis	0.00014	0.00116	CcSEcCtD
Haloperidol—Leukopenia—Zoledronate—osteoporosis	0.000139	0.00116	CcSEcCtD
Haloperidol—Oedema—Pamidronate—osteoporosis	0.000139	0.00115	CcSEcCtD
Haloperidol—Anaphylactic shock—Pamidronate—osteoporosis	0.000139	0.00115	CcSEcCtD
Haloperidol—Urticaria—Calcitriol—osteoporosis	0.000138	0.00115	CcSEcCtD
Haloperidol—Hepatitis—Estradiol—osteoporosis	0.000138	0.00114	CcSEcCtD
Haloperidol—Body temperature increased—Calcitriol—osteoporosis	0.000137	0.00114	CcSEcCtD
Haloperidol—Hypersensitivity—Estropipate—osteoporosis	0.000136	0.00113	CcSEcCtD
Haloperidol—Nervous system disorder—Pamidronate—osteoporosis	0.000136	0.00113	CcSEcCtD
Haloperidol—Thrombocytopenia—Pamidronate—osteoporosis	0.000136	0.00113	CcSEcCtD
Haloperidol—Urinary tract disorder—Estradiol—osteoporosis	0.000136	0.00113	CcSEcCtD
Haloperidol—Vomiting—Etidronic acid—osteoporosis	0.000136	0.00113	CcSEcCtD
Haloperidol—Tachycardia—Pamidronate—osteoporosis	0.000136	0.00113	CcSEcCtD
Haloperidol—Connective tissue disorder—Estradiol—osteoporosis	0.000135	0.00112	CcSEcCtD
Haloperidol—Urethral disorder—Estradiol—osteoporosis	0.000135	0.00112	CcSEcCtD
Haloperidol—Rash—Etidronic acid—osteoporosis	0.000135	0.00112	CcSEcCtD
Haloperidol—Convulsion—Zoledronate—osteoporosis	0.000135	0.00112	CcSEcCtD
Haloperidol—Dermatitis—Etidronic acid—osteoporosis	0.000135	0.00112	CcSEcCtD
Haloperidol—Vertigo—Conjugated Estrogens—osteoporosis	0.000135	0.00112	CcSEcCtD
Haloperidol—Hyperhidrosis—Pamidronate—osteoporosis	0.000134	0.00112	CcSEcCtD
Haloperidol—Hypertension—Zoledronate—osteoporosis	0.000134	0.00111	CcSEcCtD
Haloperidol—Hypersensitivity—Alendronate—osteoporosis	0.000134	0.00111	CcSEcCtD
Haloperidol—Headache—Etidronic acid—osteoporosis	0.000134	0.00111	CcSEcCtD
Haloperidol—Visual impairment—Estradiol—osteoporosis	0.000133	0.0011	CcSEcCtD
Haloperidol—Anorexia—Pamidronate—osteoporosis	0.000133	0.0011	CcSEcCtD
Haloperidol—Insomnia—Risedronate—osteoporosis	0.000132	0.0011	CcSEcCtD
Haloperidol—Anxiety—Zoledronate—osteoporosis	0.000132	0.0011	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000132	0.00109	CcSEcCtD
Haloperidol—Pruritus—Estropipate—osteoporosis	0.000131	0.00109	CcSEcCtD
Haloperidol—Hypersensitivity—Ibandronate—osteoporosis	0.000131	0.00108	CcSEcCtD
Haloperidol—Dyspnoea—Risedronate—osteoporosis	0.00013	0.00108	CcSEcCtD
Haloperidol—Hypotension—Pamidronate—osteoporosis	0.00013	0.00108	CcSEcCtD
Haloperidol—Convulsion—Conjugated Estrogens—osteoporosis	0.00013	0.00108	CcSEcCtD
Haloperidol—Dry mouth—Zoledronate—osteoporosis	0.00013	0.00107	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00013	0.00107	CcSEcCtD
Haloperidol—Pruritus—Alendronate—osteoporosis	0.000129	0.00107	CcSEcCtD
Haloperidol—Dyspepsia—Risedronate—osteoporosis	0.000129	0.00107	CcSEcCtD
Haloperidol—Eye disorder—Estradiol—osteoporosis	0.000129	0.00107	CcSEcCtD
Haloperidol—Constipation—Ethinyl Estradiol—osteoporosis	0.000128	0.00106	CcSEcCtD
Haloperidol—Confusional state—Zoledronate—osteoporosis	0.000128	0.00106	CcSEcCtD
Haloperidol—Hypersensitivity—Calcitriol—osteoporosis	0.000128	0.00106	CcSEcCtD
Haloperidol—Cardiac disorder—Estradiol—osteoporosis	0.000128	0.00106	CcSEcCtD
Haloperidol—Anxiety—Conjugated Estrogens—osteoporosis	0.000127	0.00105	CcSEcCtD
Haloperidol—Nausea—Etidronic acid—osteoporosis	0.000127	0.00105	CcSEcCtD
Haloperidol—Anaphylactic shock—Zoledronate—osteoporosis	0.000127	0.00105	CcSEcCtD
Haloperidol—Oedema—Zoledronate—osteoporosis	0.000127	0.00105	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000127	0.00105	CcSEcCtD
Haloperidol—Diarrhoea—Estropipate—osteoporosis	0.000127	0.00105	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Risedronate—osteoporosis	0.000126	0.00105	CcSEcCtD
Haloperidol—Insomnia—Pamidronate—osteoporosis	0.000126	0.00104	CcSEcCtD
Haloperidol—Pruritus—Ibandronate—osteoporosis	0.000126	0.00104	CcSEcCtD
Haloperidol—Constipation—Risedronate—osteoporosis	0.000125	0.00104	CcSEcCtD
Haloperidol—Angiopathy—Estradiol—osteoporosis	0.000125	0.00104	CcSEcCtD
Haloperidol—Diarrhoea—Alendronate—osteoporosis	0.000125	0.00103	CcSEcCtD
Haloperidol—Nervous system disorder—Zoledronate—osteoporosis	0.000125	0.00103	CcSEcCtD
Haloperidol—Immune system disorder—Estradiol—osteoporosis	0.000124	0.00103	CcSEcCtD
Haloperidol—Thrombocytopenia—Zoledronate—osteoporosis	0.000124	0.00103	CcSEcCtD
Haloperidol—Mediastinal disorder—Estradiol—osteoporosis	0.000124	0.00103	CcSEcCtD
Haloperidol—Dyspnoea—Pamidronate—osteoporosis	0.000124	0.00103	CcSEcCtD
Haloperidol—Tachycardia—Zoledronate—osteoporosis	0.000124	0.00103	CcSEcCtD
Haloperidol—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000124	0.00103	CcSEcCtD
Haloperidol—Somnolence—Pamidronate—osteoporosis	0.000124	0.00103	CcSEcCtD
Haloperidol—Skin disorder—Zoledronate—osteoporosis	0.000123	0.00102	CcSEcCtD
Haloperidol—Pruritus—Calcitriol—osteoporosis	0.000123	0.00102	CcSEcCtD
Haloperidol—Hyperhidrosis—Zoledronate—osteoporosis	0.000123	0.00102	CcSEcCtD
Haloperidol—Diarrhoea—Raloxifene—osteoporosis	0.000123	0.00102	CcSEcCtD
Haloperidol—Dyspepsia—Pamidronate—osteoporosis	0.000122	0.00102	CcSEcCtD
Haloperidol—Dizziness—Estropipate—osteoporosis	0.000122	0.00102	CcSEcCtD
Haloperidol—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000122	0.00101	CcSEcCtD
Haloperidol—Oedema—Conjugated Estrogens—osteoporosis	0.000122	0.00101	CcSEcCtD
Haloperidol—Alopecia—Estradiol—osteoporosis	0.000122	0.00101	CcSEcCtD
Haloperidol—Diarrhoea—Ibandronate—osteoporosis	0.000121	0.00101	CcSEcCtD
Haloperidol—Anorexia—Zoledronate—osteoporosis	0.000121	0.001	CcSEcCtD
Haloperidol—Decreased appetite—Pamidronate—osteoporosis	0.000121	0.001	CcSEcCtD
Haloperidol—Mental disorder—Estradiol—osteoporosis	0.000121	0.001	CcSEcCtD
Haloperidol—Dizziness—Alendronate—osteoporosis	0.000121	0.001	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00012	0.000996	CcSEcCtD
Haloperidol—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00012	0.000995	CcSEcCtD
Haloperidol—Malnutrition—Estradiol—osteoporosis	0.00012	0.000995	CcSEcCtD
Haloperidol—Tachycardia—Conjugated Estrogens—osteoporosis	0.000119	0.00099	CcSEcCtD
Haloperidol—Urticaria—Ethinyl Estradiol—osteoporosis	0.000119	0.000989	CcSEcCtD
Haloperidol—Constipation—Pamidronate—osteoporosis	0.000119	0.000986	CcSEcCtD
Haloperidol—Diarrhoea—Calcitriol—osteoporosis	0.000119	0.000986	CcSEcCtD
Haloperidol—Skin disorder—Conjugated Estrogens—osteoporosis	0.000119	0.000985	CcSEcCtD
Haloperidol—Hypotension—Zoledronate—osteoporosis	0.000119	0.000985	CcSEcCtD
Haloperidol—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000119	0.000984	CcSEcCtD
Haloperidol—Dizziness—Raloxifene—osteoporosis	0.000119	0.000984	CcSEcCtD
Haloperidol—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000118	0.000981	CcSEcCtD
Haloperidol—Vomiting—Estropipate—osteoporosis	0.000118	0.000976	CcSEcCtD
Haloperidol—Dizziness—Ibandronate—osteoporosis	0.000117	0.000974	CcSEcCtD
Haloperidol—Rash—Estropipate—osteoporosis	0.000117	0.000968	CcSEcCtD
Haloperidol—Dermatitis—Estropipate—osteoporosis	0.000117	0.000967	CcSEcCtD
Haloperidol—Anorexia—Conjugated Estrogens—osteoporosis	0.000117	0.000967	CcSEcCtD
Haloperidol—Urticaria—Risedronate—osteoporosis	0.000116	0.000964	CcSEcCtD
Haloperidol—Headache—Estropipate—osteoporosis	0.000116	0.000962	CcSEcCtD
Haloperidol—Vomiting—Alendronate—osteoporosis	0.000116	0.000962	CcSEcCtD
Haloperidol—Body temperature increased—Risedronate—osteoporosis	0.000116	0.000959	CcSEcCtD
Haloperidol—Muscle spasms—Estradiol—osteoporosis	0.000115	0.000957	CcSEcCtD
Haloperidol—Rash—Alendronate—osteoporosis	0.000115	0.000954	CcSEcCtD
Haloperidol—Insomnia—Zoledronate—osteoporosis	0.000115	0.000953	CcSEcCtD
Haloperidol—Dermatitis—Alendronate—osteoporosis	0.000115	0.000953	CcSEcCtD
Haloperidol—Feeling abnormal—Pamidronate—osteoporosis	0.000115	0.000951	CcSEcCtD
Haloperidol—Hypotension—Conjugated Estrogens—osteoporosis	0.000114	0.000948	CcSEcCtD
Haloperidol—Headache—Alendronate—osteoporosis	0.000114	0.000947	CcSEcCtD
Haloperidol—Vomiting—Raloxifene—osteoporosis	0.000114	0.000946	CcSEcCtD
Haloperidol—Dyspnoea—Zoledronate—osteoporosis	0.000113	0.000939	CcSEcCtD
Haloperidol—Rash—Raloxifene—osteoporosis	0.000113	0.000938	CcSEcCtD
Haloperidol—Dermatitis—Raloxifene—osteoporosis	0.000113	0.000937	CcSEcCtD
Haloperidol—Somnolence—Zoledronate—osteoporosis	0.000113	0.000937	CcSEcCtD
Haloperidol—Vomiting—Ibandronate—osteoporosis	0.000113	0.000936	CcSEcCtD
Haloperidol—Tremor—Estradiol—osteoporosis	0.000112	0.000932	CcSEcCtD
Haloperidol—Headache—Raloxifene—osteoporosis	0.000112	0.000932	CcSEcCtD
Haloperidol—Rash—Ibandronate—osteoporosis	0.000112	0.000928	CcSEcCtD
Haloperidol—Dermatitis—Ibandronate—osteoporosis	0.000112	0.000928	CcSEcCtD
Haloperidol—Dyspepsia—Zoledronate—osteoporosis	0.000112	0.000928	CcSEcCtD
Haloperidol—Headache—Ibandronate—osteoporosis	0.000111	0.000922	CcSEcCtD
Haloperidol—Insomnia—Conjugated Estrogens—osteoporosis	0.000111	0.000918	CcSEcCtD
Haloperidol—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000111	0.000917	CcSEcCtD
Haloperidol—Vomiting—Calcitriol—osteoporosis	0.00011	0.000916	CcSEcCtD
Haloperidol—Decreased appetite—Zoledronate—osteoporosis	0.00011	0.000916	CcSEcCtD
Haloperidol—Agitation—Estradiol—osteoporosis	0.00011	0.000914	CcSEcCtD
Haloperidol—Nausea—Estropipate—osteoporosis	0.00011	0.000912	CcSEcCtD
Haloperidol—Body temperature increased—Pamidronate—osteoporosis	0.00011	0.000912	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00011	0.00091	CcSEcCtD
Haloperidol—Rash—Calcitriol—osteoporosis	0.00011	0.000909	CcSEcCtD
Haloperidol—Dermatitis—Calcitriol—osteoporosis	0.000109	0.000908	CcSEcCtD
Haloperidol—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000109	0.000905	CcSEcCtD
Haloperidol—Headache—Calcitriol—osteoporosis	0.000109	0.000903	CcSEcCtD
Haloperidol—Somnolence—Conjugated Estrogens—osteoporosis	0.000109	0.000902	CcSEcCtD
Haloperidol—Constipation—Zoledronate—osteoporosis	0.000109	0.000901	CcSEcCtD
Haloperidol—Nausea—Alendronate—osteoporosis	0.000108	0.000898	CcSEcCtD
Haloperidol—Hypersensitivity—Risedronate—osteoporosis	0.000108	0.000894	CcSEcCtD
Haloperidol—Vertigo—Estradiol—osteoporosis	0.000108	0.000894	CcSEcCtD
Haloperidol—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000108	0.000893	CcSEcCtD
Haloperidol—Nausea—Raloxifene—osteoporosis	0.000107	0.000883	CcSEcCtD
Haloperidol—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000106	0.000882	CcSEcCtD
Haloperidol—Pruritus—Ethinyl Estradiol—osteoporosis	0.000106	0.000881	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000106	0.000876	CcSEcCtD
Haloperidol—Nausea—Ibandronate—osteoporosis	0.000105	0.000875	CcSEcCtD
Haloperidol—Feeling abnormal—Zoledronate—osteoporosis	0.000105	0.000868	CcSEcCtD
Haloperidol—Constipation—Conjugated Estrogens—osteoporosis	0.000105	0.000868	CcSEcCtD
Haloperidol—Hypertension—Estradiol—osteoporosis	0.000104	0.000859	CcSEcCtD
Haloperidol—Pruritus—Risedronate—osteoporosis	0.000104	0.000859	CcSEcCtD
Haloperidol—Nausea—Calcitriol—osteoporosis	0.000103	0.000856	CcSEcCtD
Haloperidol—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000103	0.000852	CcSEcCtD
Haloperidol—Hypersensitivity—Pamidronate—osteoporosis	0.000102	0.00085	CcSEcCtD
Haloperidol—Anxiety—Estradiol—osteoporosis	0.000102	0.000844	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000101	0.000841	CcSEcCtD
Haloperidol—Urticaria—Zoledronate—osteoporosis	0.000101	0.000837	CcSEcCtD
Haloperidol—Body temperature increased—Zoledronate—osteoporosis	0.0001	0.000833	CcSEcCtD
Haloperidol—Diarrhoea—Risedronate—osteoporosis	0.0001	0.00083	CcSEcCtD
Haloperidol—Dry mouth—Estradiol—osteoporosis	9.99e-05	0.000828	CcSEcCtD
Haloperidol—Dizziness—Ethinyl Estradiol—osteoporosis	9.92e-05	0.000823	CcSEcCtD
Haloperidol—Confusional state—Estradiol—osteoporosis	9.87e-05	0.000819	CcSEcCtD
Haloperidol—Pruritus—Pamidronate—osteoporosis	9.84e-05	0.000816	CcSEcCtD
Haloperidol—Oedema—Estradiol—osteoporosis	9.79e-05	0.000812	CcSEcCtD
Haloperidol—Anaphylactic shock—Estradiol—osteoporosis	9.79e-05	0.000812	CcSEcCtD
Haloperidol—Urticaria—Conjugated Estrogens—osteoporosis	9.72e-05	0.000806	CcSEcCtD
Haloperidol—Dizziness—Risedronate—osteoporosis	9.67e-05	0.000802	CcSEcCtD
Haloperidol—Body temperature increased—Conjugated Estrogens—osteoporosis	9.67e-05	0.000802	CcSEcCtD
Haloperidol—Nervous system disorder—Estradiol—osteoporosis	9.6e-05	0.000796	CcSEcCtD
Haloperidol—Tachycardia—Estradiol—osteoporosis	9.55e-05	0.000792	CcSEcCtD
Haloperidol—Vomiting—Ethinyl Estradiol—osteoporosis	9.54e-05	0.000791	CcSEcCtD
Haloperidol—Diarrhoea—Pamidronate—osteoporosis	9.52e-05	0.000789	CcSEcCtD
Haloperidol—Skin disorder—Estradiol—osteoporosis	9.51e-05	0.000789	CcSEcCtD
Haloperidol—Hyperhidrosis—Estradiol—osteoporosis	9.46e-05	0.000785	CcSEcCtD
Haloperidol—Rash—Ethinyl Estradiol—osteoporosis	9.46e-05	0.000785	CcSEcCtD
Haloperidol—Dermatitis—Ethinyl Estradiol—osteoporosis	9.45e-05	0.000784	CcSEcCtD
Haloperidol—Headache—Ethinyl Estradiol—osteoporosis	9.4e-05	0.00078	CcSEcCtD
Haloperidol—Hypersensitivity—Zoledronate—osteoporosis	9.36e-05	0.000776	CcSEcCtD
Haloperidol—Vomiting—Risedronate—osteoporosis	9.3e-05	0.000772	CcSEcCtD
Haloperidol—Rash—Risedronate—osteoporosis	9.22e-05	0.000765	CcSEcCtD
Haloperidol—Dermatitis—Risedronate—osteoporosis	9.22e-05	0.000764	CcSEcCtD
Haloperidol—Dizziness—Pamidronate—osteoporosis	9.2e-05	0.000763	CcSEcCtD
Haloperidol—Headache—Risedronate—osteoporosis	9.17e-05	0.00076	CcSEcCtD
Haloperidol—Hypersensitivity—Conjugated Estrogens—osteoporosis	9.01e-05	0.000747	CcSEcCtD
Haloperidol—Pruritus—Zoledronate—osteoporosis	8.99e-05	0.000745	CcSEcCtD
Haloperidol—Nausea—Ethinyl Estradiol—osteoporosis	8.91e-05	0.000739	CcSEcCtD
Haloperidol—Insomnia—Estradiol—osteoporosis	8.85e-05	0.000734	CcSEcCtD
Haloperidol—Vomiting—Pamidronate—osteoporosis	8.84e-05	0.000733	CcSEcCtD
Haloperidol—Rash—Pamidronate—osteoporosis	8.77e-05	0.000727	CcSEcCtD
Haloperidol—Dermatitis—Pamidronate—osteoporosis	8.76e-05	0.000727	CcSEcCtD
Haloperidol—Dyspnoea—Estradiol—osteoporosis	8.73e-05	0.000724	CcSEcCtD
Haloperidol—Headache—Pamidronate—osteoporosis	8.71e-05	0.000723	CcSEcCtD
Haloperidol—Somnolence—Estradiol—osteoporosis	8.7e-05	0.000722	CcSEcCtD
Haloperidol—Diarrhoea—Zoledronate—osteoporosis	8.69e-05	0.000721	CcSEcCtD
Haloperidol—Nausea—Risedronate—osteoporosis	8.69e-05	0.000721	CcSEcCtD
Haloperidol—Pruritus—Conjugated Estrogens—osteoporosis	8.65e-05	0.000718	CcSEcCtD
Haloperidol—Dyspepsia—Estradiol—osteoporosis	8.62e-05	0.000715	CcSEcCtD
Haloperidol—Decreased appetite—Estradiol—osteoporosis	8.51e-05	0.000706	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Estradiol—osteoporosis	8.45e-05	0.000701	CcSEcCtD
Haloperidol—Dizziness—Zoledronate—osteoporosis	8.4e-05	0.000697	CcSEcCtD
Haloperidol—Constipation—Estradiol—osteoporosis	8.37e-05	0.000694	CcSEcCtD
Haloperidol—Diarrhoea—Conjugated Estrogens—osteoporosis	8.37e-05	0.000694	CcSEcCtD
Haloperidol—Nausea—Pamidronate—osteoporosis	8.26e-05	0.000685	CcSEcCtD
Haloperidol—Dizziness—Conjugated Estrogens—osteoporosis	8.09e-05	0.000671	CcSEcCtD
Haloperidol—Vomiting—Zoledronate—osteoporosis	8.08e-05	0.00067	CcSEcCtD
Haloperidol—Feeling abnormal—Estradiol—osteoporosis	8.07e-05	0.000669	CcSEcCtD
Haloperidol—Rash—Zoledronate—osteoporosis	8.01e-05	0.000664	CcSEcCtD
Haloperidol—Dermatitis—Zoledronate—osteoporosis	8e-05	0.000664	CcSEcCtD
Haloperidol—Headache—Zoledronate—osteoporosis	7.96e-05	0.00066	CcSEcCtD
Haloperidol—Vomiting—Conjugated Estrogens—osteoporosis	7.78e-05	0.000645	CcSEcCtD
Haloperidol—Urticaria—Estradiol—osteoporosis	7.78e-05	0.000645	CcSEcCtD
Haloperidol—Body temperature increased—Estradiol—osteoporosis	7.74e-05	0.000642	CcSEcCtD
Haloperidol—Rash—Conjugated Estrogens—osteoporosis	7.71e-05	0.00064	CcSEcCtD
Haloperidol—Dermatitis—Conjugated Estrogens—osteoporosis	7.71e-05	0.000639	CcSEcCtD
Haloperidol—Headache—Conjugated Estrogens—osteoporosis	7.66e-05	0.000636	CcSEcCtD
Haloperidol—Nausea—Zoledronate—osteoporosis	7.55e-05	0.000626	CcSEcCtD
Haloperidol—Nausea—Conjugated Estrogens—osteoporosis	7.27e-05	0.000603	CcSEcCtD
Haloperidol—Hypersensitivity—Estradiol—osteoporosis	7.21e-05	0.000598	CcSEcCtD
Haloperidol—Pruritus—Estradiol—osteoporosis	6.93e-05	0.000574	CcSEcCtD
Haloperidol—Diarrhoea—Estradiol—osteoporosis	6.7e-05	0.000556	CcSEcCtD
Haloperidol—Dizziness—Estradiol—osteoporosis	6.47e-05	0.000537	CcSEcCtD
Haloperidol—Vomiting—Estradiol—osteoporosis	6.22e-05	0.000516	CcSEcCtD
Haloperidol—Rash—Estradiol—osteoporosis	6.17e-05	0.000512	CcSEcCtD
Haloperidol—Dermatitis—Estradiol—osteoporosis	6.17e-05	0.000512	CcSEcCtD
Haloperidol—Headache—Estradiol—osteoporosis	6.13e-05	0.000509	CcSEcCtD
Haloperidol—Nausea—Estradiol—osteoporosis	5.81e-05	0.000482	CcSEcCtD
Haloperidol—CYP2C9—Metabolism—ACP5—osteoporosis	7.57e-06	0.000166	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—FGB—osteoporosis	7.55e-06	0.000166	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—TPI1—osteoporosis	7.54e-06	0.000166	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	7.48e-06	0.000164	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—FGB—osteoporosis	7.43e-06	0.000163	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—FGB—osteoporosis	7.41e-06	0.000163	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.4e-06	0.000163	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—ADCY5—osteoporosis	7.38e-06	0.000162	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PSMA2—osteoporosis	7.29e-06	0.00016	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PSMA5—osteoporosis	7.29e-06	0.00016	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—P4HB—osteoporosis	7.26e-06	0.00016	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—ENO1—osteoporosis	7.26e-06	0.000159	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—ADCY5—osteoporosis	7.22e-06	0.000159	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PSMA2—osteoporosis	7.17e-06	0.000158	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PSMA5—osteoporosis	7.17e-06	0.000158	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—MTHFR—osteoporosis	7.17e-06	0.000158	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PSMA5—osteoporosis	7.16e-06	0.000157	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PSMA2—osteoporosis	7.16e-06	0.000157	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PSMA2—osteoporosis	7.15e-06	0.000157	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PSMA5—osteoporosis	7.15e-06	0.000157	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—SPP1—osteoporosis	7.14e-06	0.000157	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—GAPDH—osteoporosis	7.12e-06	0.000157	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—ADCY5—osteoporosis	7.11e-06	0.000156	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—TPI1—osteoporosis	7.1e-06	0.000156	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—P4HB—osteoporosis	7.08e-06	0.000156	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—IDH2—osteoporosis	7.07e-06	0.000156	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—TPI1—osteoporosis	7.04e-06	0.000155	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—SPP1—osteoporosis	6.99e-06	0.000154	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—GAPDH—osteoporosis	6.95e-06	0.000153	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—RAP1A—osteoporosis	6.94e-06	0.000153	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—SPP1—osteoporosis	6.88e-06	0.000151	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—ENO1—osteoporosis	6.85e-06	0.000151	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CALCA—osteoporosis	6.79e-06	0.000149	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—ADCY5—osteoporosis	6.78e-06	0.000149	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—RAP1A—osteoporosis	6.77e-06	0.000149	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PSMA2—osteoporosis	6.75e-06	0.000148	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PSMA5—osteoporosis	6.75e-06	0.000148	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CALCA—osteoporosis	6.68e-06	0.000147	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—P4HB—osteoporosis	6.68e-06	0.000147	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CALCA—osteoporosis	6.67e-06	0.000147	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CYP27A1—osteoporosis	6.65e-06	0.000146	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—POMC—osteoporosis	6.62e-06	0.000146	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—P4HB—osteoporosis	6.62e-06	0.000145	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—OXCT1—osteoporosis	6.59e-06	0.000145	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CA2—osteoporosis	6.59e-06	0.000145	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—SPP1—osteoporosis	6.56e-06	0.000144	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—ADCY5—osteoporosis	6.56e-06	0.000144	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GAPDH—osteoporosis	6.55e-06	0.000144	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—GPX1—osteoporosis	6.53e-06	0.000144	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—POMC—osteoporosis	6.52e-06	0.000143	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—POMC—osteoporosis	6.5e-06	0.000143	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GAPDH—osteoporosis	6.5e-06	0.000143	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ACP5—osteoporosis	6.47e-06	0.000142	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IRS2—osteoporosis	6.45e-06	0.000142	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—MGLL—osteoporosis	6.42e-06	0.000141	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—ADCY5—osteoporosis	6.4e-06	0.000141	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.39e-06	0.00014	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—RAP1A—osteoporosis	6.38e-06	0.00014	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—RAP1A—osteoporosis	6.33e-06	0.000139	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IRS2—osteoporosis	6.32e-06	0.000139	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—LEP—osteoporosis	6.32e-06	0.000139	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—ADCY5—osteoporosis	6.31e-06	0.000139	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IRS2—osteoporosis	6.22e-06	0.000137	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—SPP1—osteoporosis	6.19e-06	0.000136	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—LEP—osteoporosis	6.18e-06	0.000136	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—KL—osteoporosis	6.17e-06	0.000136	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—SPP1—osteoporosis	6.11e-06	0.000134	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—LEP—osteoporosis	6.09e-06	0.000134	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—KL—osteoporosis	6.07e-06	0.000133	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—KL—osteoporosis	6.05e-06	0.000133	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.05e-06	0.000133	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—MTHFR—osteoporosis	6.03e-06	0.000133	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—ESR1—osteoporosis	6.03e-06	0.000133	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—TPI1—osteoporosis	6.02e-06	0.000132	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—POMC—osteoporosis	6.02e-06	0.000132	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IRS2—osteoporosis	5.94e-06	0.00013	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—POMC—osteoporosis	5.92e-06	0.00013	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—POMC—osteoporosis	5.91e-06	0.00013	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—ESR1—osteoporosis	5.9e-06	0.00013	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—IL6R—osteoporosis	5.87e-06	0.000129	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—ESR1—osteoporosis	5.81e-06	0.000128	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—LEP—osteoporosis	5.81e-06	0.000128	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—CYP19A1—osteoporosis	5.8e-06	0.000127	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—IL6R—osteoporosis	5.77e-06	0.000127	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—IL6R—osteoporosis	5.76e-06	0.000127	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—POMC—osteoporosis	5.73e-06	0.000126	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—P4HB—osteoporosis	5.66e-06	0.000124	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IRS1—osteoporosis	5.63e-06	0.000124	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ENO1—osteoporosis	5.61e-06	0.000123	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IRS2—osteoporosis	5.6e-06	0.000123	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GAPDH—osteoporosis	5.55e-06	0.000122	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—ESR1—osteoporosis	5.55e-06	0.000122	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PSMA5—osteoporosis	5.53e-06	0.000121	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PSMA2—osteoporosis	5.53e-06	0.000121	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IRS2—osteoporosis	5.52e-06	0.000121	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.52e-06	0.000121	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IRS1—osteoporosis	5.52e-06	0.000121	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—CYP19A1—osteoporosis	5.48e-06	0.00012	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—LEP—osteoporosis	5.48e-06	0.00012	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ENO1—osteoporosis	5.48e-06	0.00012	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—IDH2—osteoporosis	5.46e-06	0.00012	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IRS1—osteoporosis	5.43e-06	0.000119	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—POMC—osteoporosis	5.43e-06	0.000119	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—RAP1A—osteoporosis	5.41e-06	0.000119	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—LEP—osteoporosis	5.41e-06	0.000119	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PSMA2—osteoporosis	5.4e-06	0.000119	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PSMA5—osteoporosis	5.4e-06	0.000119	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—POMC—osteoporosis	5.31e-06	0.000117	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IL6R—osteoporosis	5.29e-06	0.000116	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—ESR1—osteoporosis	5.23e-06	0.000115	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—POMC—osteoporosis	5.23e-06	0.000115	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IGF1—osteoporosis	5.22e-06	0.000115	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IRS1—osteoporosis	5.18e-06	0.000114	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IL6R—osteoporosis	5.18e-06	0.000114	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—ESR1—osteoporosis	5.16e-06	0.000113	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ENO1—osteoporosis	5.16e-06	0.000113	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CYP27A1—osteoporosis	5.13e-06	0.000113	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ENO1—osteoporosis	5.11e-06	0.000112	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IGF1—osteoporosis	5.11e-06	0.000112	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IL6R—osteoporosis	5.1e-06	0.000112	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PSMA5—osteoporosis	5.08e-06	0.000112	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PSMA2—osteoporosis	5.08e-06	0.000112	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PSMA2—osteoporosis	5.04e-06	0.000111	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PSMA5—osteoporosis	5.04e-06	0.000111	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IGF1—osteoporosis	5.03e-06	0.000111	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ACP5—osteoporosis	4.99e-06	0.00011	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—POMC—osteoporosis	4.99e-06	0.00011	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IRS1—osteoporosis	4.89e-06	0.000107	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IL6R—osteoporosis	4.87e-06	0.000107	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—ADCY5—osteoporosis	4.83e-06	0.000106	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—POMC—osteoporosis	4.82e-06	0.000106	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IRS1—osteoporosis	4.82e-06	0.000106	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IGF1—osteoporosis	4.8e-06	0.000106	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—ADCY5—osteoporosis	4.75e-06	0.000104	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—ADCY5—osteoporosis	4.74e-06	0.000104	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—ADCY5—osteoporosis	4.74e-06	0.000104	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—GPX1—osteoporosis	4.72e-06	0.000104	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.72e-06	0.000104	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—POMC—osteoporosis	4.71e-06	0.000103	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SPP1—osteoporosis	4.67e-06	0.000103	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—POMC—osteoporosis	4.64e-06	0.000102	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—TPI1—osteoporosis	4.64e-06	0.000102	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SPP1—osteoporosis	4.6e-06	0.000101	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IL6R—osteoporosis	4.59e-06	0.000101	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SPP1—osteoporosis	4.59e-06	0.000101	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IL6R—osteoporosis	4.53e-06	9.96e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IGF1—osteoporosis	4.53e-06	9.95e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CYP19A1—osteoporosis	4.48e-06	9.86e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—ADCY5—osteoporosis	4.48e-06	9.84e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IGF1—osteoporosis	4.47e-06	9.82e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—GPX1—osteoporosis	4.46e-06	9.81e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CYP19A1—osteoporosis	4.38e-06	9.62e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ENO1—osteoporosis	4.37e-06	9.61e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—P4HB—osteoporosis	4.36e-06	9.59e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—MTHFR—osteoporosis	4.36e-06	9.58e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PSMA2—osteoporosis	4.31e-06	9.47e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PSMA5—osteoporosis	4.31e-06	9.47e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GAPDH—osteoporosis	4.28e-06	9.42e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IRS2—osteoporosis	4.23e-06	9.29e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—RAP1A—osteoporosis	4.17e-06	9.17e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IRS2—osteoporosis	4.16e-06	9.14e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IRS2—osteoporosis	4.15e-06	9.12e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—LEP—osteoporosis	4.14e-06	9.09e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CYP19A1—osteoporosis	4.12e-06	9.07e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—MTHFR—osteoporosis	4.12e-06	9.05e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CYP19A1—osteoporosis	4.09e-06	8.99e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—LEP—osteoporosis	4.07e-06	8.95e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—LEP—osteoporosis	4.06e-06	8.93e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—IL6—osteoporosis	3.99e-06	8.77e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—ESR1—osteoporosis	3.95e-06	8.68e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—IL6—osteoporosis	3.91e-06	8.59e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—ESR1—osteoporosis	3.89e-06	8.54e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—ESR1—osteoporosis	3.88e-06	8.52e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—IL6—osteoporosis	3.85e-06	8.45e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IRS1—osteoporosis	3.69e-06	8.11e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—IL6—osteoporosis	3.67e-06	8.07e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ADCY5—osteoporosis	3.66e-06	8.05e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—GPX1—osteoporosis	3.65e-06	8.03e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IRS1—osteoporosis	3.63e-06	7.98e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IRS1—osteoporosis	3.62e-06	7.96e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ADCY5—osteoporosis	3.58e-06	7.86e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—GPX1—osteoporosis	3.56e-06	7.83e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—POMC—osteoporosis	3.55e-06	7.81e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—POMC—osteoporosis	3.5e-06	7.69e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CYP19A1—osteoporosis	3.49e-06	7.68e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—POMC—osteoporosis	3.49e-06	7.67e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—POMC—osteoporosis	3.49e-06	7.66e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL6R—osteoporosis	3.47e-06	7.62e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—IL6—osteoporosis	3.46e-06	7.61e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IGF1—osteoporosis	3.42e-06	7.51e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—IL6—osteoporosis	3.42e-06	7.51e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL6R—osteoporosis	3.41e-06	7.5e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL6R—osteoporosis	3.4e-06	7.48e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ENO1—osteoporosis	3.37e-06	7.41e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ADCY5—osteoporosis	3.37e-06	7.41e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—MTHFR—osteoporosis	3.37e-06	7.41e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IGF1—osteoporosis	3.36e-06	7.39e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GPX1—osteoporosis	3.36e-06	7.38e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IGF1—osteoporosis	3.36e-06	7.38e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ADCY5—osteoporosis	3.34e-06	7.34e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GPX1—osteoporosis	3.33e-06	7.32e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PSMA2—osteoporosis	3.32e-06	7.31e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PSMA5—osteoporosis	3.32e-06	7.31e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—POMC—osteoporosis	3.29e-06	7.24e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—MTHFR—osteoporosis	3.29e-06	7.23e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MYC—osteoporosis	3.14e-06	6.89e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TGFB1—osteoporosis	3.13e-06	6.88e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—MTHFR—osteoporosis	3.1e-06	6.81e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—MTHFR—osteoporosis	3.07e-06	6.75e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MYC—osteoporosis	3.07e-06	6.75e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TGFB1—osteoporosis	3.06e-06	6.73e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MYC—osteoporosis	3.02e-06	6.64e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TGFB1—osteoporosis	3.01e-06	6.63e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MYC—osteoporosis	2.88e-06	6.34e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TGFB1—osteoporosis	2.88e-06	6.33e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ADCY5—osteoporosis	2.85e-06	6.28e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GPX1—osteoporosis	2.85e-06	6.25e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MYC—osteoporosis	2.72e-06	5.98e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TGFB1—osteoporosis	2.71e-06	5.97e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CYP19A1—osteoporosis	2.7e-06	5.93e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—POMC—osteoporosis	2.7e-06	5.92e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MYC—osteoporosis	2.68e-06	5.9e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TGFB1—osteoporosis	2.68e-06	5.89e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—POMC—osteoporosis	2.63e-06	5.78e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—MTHFR—osteoporosis	2.63e-06	5.77e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—IL6—osteoporosis	2.61e-06	5.75e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—IL6—osteoporosis	2.57e-06	5.65e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—IL6—osteoporosis	2.57e-06	5.64e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—POMC—osteoporosis	2.48e-06	5.45e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—POMC—osteoporosis	2.46e-06	5.4e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IL6—osteoporosis	2.36e-06	5.18e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IL6—osteoporosis	2.31e-06	5.07e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IL6—osteoporosis	2.27e-06	4.99e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ADCY5—osteoporosis	2.2e-06	4.84e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GPX1—osteoporosis	2.2e-06	4.83e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IL6—osteoporosis	2.17e-06	4.77e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—POMC—osteoporosis	2.1e-06	4.62e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MYC—osteoporosis	2.05e-06	4.51e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TGFB1—osteoporosis	2.05e-06	4.5e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IL6—osteoporosis	2.05e-06	4.5e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—MTHFR—osteoporosis	2.03e-06	4.45e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MYC—osteoporosis	2.02e-06	4.44e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IL6—osteoporosis	2.02e-06	4.44e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MYC—osteoporosis	2.02e-06	4.43e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TGFB1—osteoporosis	2.02e-06	4.43e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TGFB1—osteoporosis	2.01e-06	4.42e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—POMC—osteoporosis	1.62e-06	3.56e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL6—osteoporosis	1.54e-06	3.39e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL6—osteoporosis	1.52e-06	3.34e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL6—osteoporosis	1.52e-06	3.33e-05	CbGpPWpGaD
